Pangenia Group's subsidiary – Pangenia Lifesciences Limited was awarded "Hong Kong Emerging Service Brand" in 2016

: 2018/06/07 17:37:54
Pangenia Group's subsidiary – Pangenia Lifesciences Limited has been seen to develop swiftly since its establishment, overhanging the genetic testing market whilst expanding its influence into China and internationally. In acceptance of their achievements, Pangenia Lifesciences Limited was awarded "Hong Kong Emerging Service Brand" in 2016.

Pangenia Lifesciences Limited adheres to its principle of “A step ahead for healthcare”. By granting its customers with high end genetic testing services, doctors can accurately determine specific treatments for their patients while strengthening the public’s knowledge of health risk management. Pangenia Lifesciences provides different healthcare services for customers at all stages of their lives. Tests include prenatal and women’s health tests, precision cancer tests and hereditary risk assessments. The “Mygenia” test developed by Pangenia Lifesciences with the technology of “Next Generation Sequencing” (NGS) to evaluate risks of hereditary disease of the tester to order to prevent varies disease at an earlier stage.

Most professional researchers employed by Pangenia Lifesciences Limited hold Ph.D degrees and have ample knowledge and experience. The company has set up its own laboratory in Hong Kong, passing the “Hong Kong Laboratory Accreditation Scheme” and have obtained “ISO 15189 : 2012” for certification of quality and competence of medical laboratories. Pangenia has developed its own test kits, instruments and reagents for some of the tests to ensure high quality of service.

Reference: Hong Kong Brand Development Council 2016

For more information: